These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12692042)

  • 1. Tegaserod and IBS: a perfect match?
    Grant Thompson W
    Gut; 2003 May; 52(5):621-2. PubMed ID: 12692042
    [No Abstract]   [Full Text] [Related]  

  • 2. Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women.
    Wagstaff AJ; Frampton JE; Croom KF
    Drugs; 2003; 63(11):1101-20. PubMed ID: 12749744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of tegaserod for the treatment of irritable bowel syndrome.
    Jones BW; Moore DJ; Robinson SM; Song F
    J Clin Pharm Ther; 2002 Oct; 27(5):343-52. PubMed ID: 12383135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome.
    Beglinger C
    Int J Clin Pract; 2002; 56(1):47-51. PubMed ID: 11831835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of tegaserod for the treatment of irritable bowel syndrome.
    Bergmann K
    J Clin Pharm Ther; 2003 Apr; 28(2):151-3; author reply 153. PubMed ID: 12713613
    [No Abstract]   [Full Text] [Related]  

  • 6. An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.
    Kellow J; Lee OY; Chang FY; Thongsawat S; Mazlam MZ; Yuen H; Gwee KA; Bak YT; Jones J; Wagner A
    Gut; 2003 May; 52(5):671-6. PubMed ID: 12692051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zelnorm: new treatment available for women with IBS.
    Nursing; 2002 Oct; 32(10):24, 26. PubMed ID: 12400584
    [No Abstract]   [Full Text] [Related]  

  • 8. Systematic review on the management of irritable bowel syndrome in North America.
    Brandt LJ; Bjorkman D; Fennerty MB; Locke GR; Olden K; Peterson W; Quigley E; Schoenfeld P; Schuster M; Talley N
    Am J Gastroenterol; 2002 Nov; 97(11 Suppl):S7-26. PubMed ID: 12425586
    [No Abstract]   [Full Text] [Related]  

  • 9. Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects.
    Morganroth J; Rüegg PC; Dunger-Baldauf C; Appel-Dingemanse S; Bliesath H; Lefkowitz M
    Am J Gastroenterol; 2002 Sep; 97(9):2321-7. PubMed ID: 12358251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials.
    Müller-Lissner S; Koch G; Talley NJ; Drossman D; Rueegg P; Dunger-Baldauf C; Lefkowitz M
    J Clin Epidemiol; 2003 Apr; 56(4):310-6. PubMed ID: 12767407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tegaserod maleate (Zelnorm) for IBS with constipation.
    Med Lett Drugs Ther; 2002 Sep; 44(1139):79-80. PubMed ID: 12237618
    [No Abstract]   [Full Text] [Related]  

  • 12. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
    Horwitz BJ
    Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacokinetics of tegaserod, a serotonin 5-HT(4) receptor partial agonist with promotile activity.
    Appel-Dingemanse S
    Clin Pharmacokinet; 2002; 41(13):1021-42. PubMed ID: 12403641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on irritable bowel syndrome.
    Bergmann KA
    Postgrad Med J; 2003 Dec; 79(938):715. PubMed ID: 14707260
    [No Abstract]   [Full Text] [Related]  

  • 17. [New drug for irritable bowel syndrome].
    Hennemann A
    Med Monatsschr Pharm; 2001 Apr; 24(4):106-8. PubMed ID: 11338633
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tegaserod in treatment of women with irritable bowel syndrome].
    Munck LK; Ainsworth MA
    Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review: incidence of abdominal/pelvic surgery amongst patients using tegaserod in randomized controlled trials.
    Schoenfeld P
    Aliment Pharmacol Ther; 2004 Feb; 19(3):263-9. PubMed ID: 14984372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. At last--a treatment for IBS beyond placebo.
    Guda N; Vaki N
    Am J Gastroenterol; 2003 May; 98(5):1195-6. PubMed ID: 12830818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.